Are nasal steroids effective in children with adenoid hypertrophy?

Fevzi SOLMAZ; Mustafa Erhan AŞÇIOĞLU; Osman DURGUT; Oğuzhan DİKİCİ; Mehmet HAKSEVER; Davut AKDUMAN

doi:https://doi.org/10.18621/eurj.405439

Makale detayları

Are nasal steroids effective in children with adenoid hypertrophy?

Yazarlar:

Fevzi SOLMAZ | Mustafa Erhan AŞÇIOĞLU | Osman DURGUT | Oğuzhan DİKİCİ | Mehmet HAKSEVER | Davut AKDUMAN

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Sağlık teşvikleri

Dergi:

The European Research Journal 2019 Vol.5 Issue 2, pp.311-318

Belge Tipi:

Makale

Yayın Tarihi:

3/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000662836

Sıklık:

İki Aylık

eISSN:

2149-3189

DOI:

https://doi.org/10.18621/eurj.405439

Özet:

 


Objectives: Chronic
nasal obstruction is a common disease of childhood. Adenotonsillar hypertrophy
plays an important role in obstructive sleep apnea. The topical use of the
aerosolized forms of corticosteroids therefore seems the most appropriate route
to decrease systemic side effects. The aim of our study is to demonstrate the
effect of topical mometasone furoate especially on the adenoid volume in
patients without any allergic story. 


Methods: The study
group consisting of 30 males and 25 females was administered topical nasal
mometasone furoate steroid treatment. The 20 patients were in the control group
where saline solution (0.9% NaCl) treatment was administered consisted of 12
males and 8 females. Nasopharyngeal X-rays before treatment revealed that 25
patients were Grade 2 and 30 patients were Grade 3 according to the Fujioka method.



Results: Flexible
endoscopy performed before the treatment revealed that 20 patients were Grade 2,
11 patients were Grade 3 and 24 patients were Grade 4. Nasal endoscopies
performed after 6 weeks of intranasal topical steroid therapy revealed that 45
patients were Grade 1 and 10 patients were Grade 2. A statistically significant
difference was present between endoscopic grades before and after treatment (p
< 0.0001). Nasal endoscopies performed after 6 weeks in control group
receiving saline solution treatment revealed Grade 2 in 7 patients, Grade 3 in
10 patients and Grade 4 in 3 patients. There was no statistically significant
difference between in the prior and later grades of the control group (p =
0.3125). 









Conclusions:
We believe that the
use of intranasal steroids (mometasone furoate) for 6 weeks in patients with
pediatric chronic nasal obstruction due to adenoid hypertrophy may be an
effective treatment modality in alleviating symptoms and decreasing adenoid
volume without causing systemic side effects. 




.

Makale detayları

Are nasal steroids effective in children with adenoid hypertrophy?

Yazarlar: Fevzi SOLMAZ | Mustafa Erhan AŞÇIOĞLU | Osman DURGUT | Oğuzhan DİKİCİ | Mehmet HAKSEVER | Davut AKDUMAN

Yayıncı: Prusa Medical Publishing

Ana Başlıklar: Sağlık teşvikleri

Dergi: The European Research Journal 2019 Vol.5 Issue 2, pp.311-318

Belge Tipi: Makale

Yayın Tarihi: 3/2019

Belge Dili: İngilizce

Document ID (Org No.): 2000662836

Sıklık: İki Aylık

eISSN: 2149-3189

DOI: https://doi.org/10.18621/eurj.405439

Sayı

Yazarlar:

Fevzi SOLMAZ | Mustafa Erhan AŞÇIOĞLU | Osman DURGUT | Oğuzhan DİKİCİ | Mehmet HAKSEVER | Davut AKDUMAN

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Sağlık teşvikleri

Dergi:

The European Research Journal 2019 Vol.5 Issue 2, pp.311-318

Belge Tipi:

Makale

Yayın Tarihi:

3/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000662836

Sıklık:

İki Aylık

eISSN:

2149-3189

DOI:

https://doi.org/10.18621/eurj.405439